BRIEF-U.S. FDA approves Juluca, a two-drug regimen for certain patients with HIV
November 21, 2017 at 14:04 PM EST
* Approved Juluca, a fixed-dose tablet containing dolutegravir and rilpivirine, to treat adults with HIV-1 infections
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|